Skip to main content

Year: 2021

Coherus BioSciences Appoints Theresa LaVallee, Ph.D., Chief Development Officer

REDWOOD CITY, Calif., Dec. 17, 2021 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced the addition of Theresa LaVallee, Ph.D. as its Chief Development Officer. Dr. LaVallee will serve as a member of the Company’s executive leadership team and oversee all regulatory matters and product development functions, reporting to Denny Lanfear, President and CEO of Coherus. “Theresa is a terrific addition to Coherus at a time when we are increasingly focused on our immuno-oncology pipeline, particularly combinations with toripalimab, our PD-1 inhibitor,” said Mr. Lanfear. “She is a seasoned executive with a proven track record of success in the end-to-end discovery and development of drugs and diagnostics for cancer. With her scientific and regulatory expertise, she will play a critical role in the growth of our...

Continue reading

TaskUs Partners with Artificial Intelligence Provider ASAPP to Offer a Customer Experience of the Future

CCW BPO of the Year, TaskUs, and Automation Solution of the Year Finalist, ASAPP, Work to Advance Digital Engagement in First Deal LAS VEGAS, Dec. 17, 2021 (GLOBE NEWSWIRE) — TaskUs, Inc. (Nasdaq: TASK), a leading digital outsourcing provider for high growth companies, has announced a strategic partnership with ASAPP, Inc., an artificial intelligence (AI) research-driven company, at Customer Contact Week (CCW). The partnership will unlock the contact center of the future powered by digitally enabled customer service teammates and AI-Native technology to elevate frontline teammates’ performance. The partnership will combine ASAPP technology with TaskUs specialized services and experience working with fast-growing technology companies to drive exemplary digital customer experience (DCX). “ASAPP and TaskUs see a clear opportunity...

Continue reading

NutraLife Biosciences Partners with KOR Medical to Create Cannabinoid-Based Wellness Products

COCONUT CREEK, FL, Dec. 17, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — NutraLife Biosciences Inc. (OTC: NLBS) announces a strategic partnership with KOR Medical and completes an initial order for a line of cannabinoid-based wellness products. The initial products produced under this venture is a line of four ingestible items formulated to help improve overall health, including helping consumers sleep better, feel better, be calmer, and improve their quality of life. Cannabinoids are natural compounds found in the cannabis plant. Dozens have been discovered, and many are known to cause different effects in the human body. One of the more well-known cannabinoids is CBD, which is said to decrease pain, reduce inflammation, and decrease anxiety. CBD is commonly extracted from industrial hemp and processed into oil and other products. NutraLife...

Continue reading

Abeona Therapeutics Announces Pricing of Public Offering of Common Stock and Warrants

NEW YORK and CLEVELAND, Dec. 17, 2021 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced the pricing of its underwritten public offering of 44,700,000 shares of its common stock and warrants to purchase 44,700,000 shares of its common stock at a combined offering price to the public of $0.39 per one share of common stock and one warrant to purchase one share of common stock. The warrants have an exercise price of $0.39 per share of common stock, are exercisable immediately, and will expire five years from the date of issuance. The aggregate gross proceeds from the offering are expected to be approximately $17.5 million, before deducting the underwriting discounts and commissions and other offering expenses payable by Abeona. The offering is expected to...

Continue reading

The RealReal Provides Notice of Proposed Settlement of Derivative Action

SAN FRANCISCO, Dec. 17, 2021 (GLOBE NEWSWIRE) — The RealReal (Nasdaq: REAL) – the world’s largest online market place for authenticated, resale luxury goods – today provided notice of proposed settlement of derivative action. IN THE UNITED STATES DISTRICT COURTFOR THE DISTRICT OF DELAWAREIN RE THE REALREAL, INC.STOCKHOLDER DERIVATIVELITIGATION Master File No.: 1:20-cv-01212-LPSTHIS DOCUMENT RELATES TO: NOTICE TO CURRENT THE REALREAL SHAREHOLDERS OF PROPOSED SETTLEMENT AND DISMISSAL WITH PREJUDICE OF DERIVATIVE ACTIONTO: ALL RECORD HOLDERS AND BENEFICIAL OWNERS OF THE REALREAL, INC. (“TRR” OR THE“COMPANY”) COMMON STOCK (TICKER SYMBOL: REAL) AS OF NOVEMBER 5, 2021.PLEASE READ THIS NOTICE CAREFULLY AND IN ITS ENTIRETY. THIS NOTICE RELATES TO A PROPOSED SETTLEMENT AND DISMISSAL WITH PREJUDICE OF STOCKHOLDER DERIVATIVE...

Continue reading

Soluna Holdings Announces LOI for the Sale of its MTI Instruments Business

NEW YORK, Dec. 17, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Soluna Holdings, Inc. (Nasdaq: SLNH), a developer of green data centers for cryptocurrency mining and other intensive computing, today announced that it has entered into a non-binding letter of intent for the potential sale of its MTI Instruments subsidiary (the “LOI”) with a strategic buyer in the test and measurement space.  Michael Toporek, CEO of Soluna Holdings, stated, “As we committed to shareholders, we would explore potential strategic transactions for our instruments business so that we could focus on being a pure play green computing, zero-carbon computing and cryptocurrency mining company. We have moved to the exclusive phase of a potential transaction.” Toporek added, “MTI is a great business with a bright future that we know will continue to...

Continue reading

EnWave Announces Grant of Restricted Share Rights and Stock Options to Directors and Officers

VANCOUVER, British Columbia, Dec. 17, 2021 (GLOBE NEWSWIRE) — EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) announced today that pursuant to the Company’s Restricted Share Rights Plan, an aggregate total of 245,000 Restricted Share Rights (“RSRs”) were awarded to the independent directors and certain officers of the Company. The RSRs granted will vest three years from the date of award on December 16, 2024. Equity incentive awards form part of the Company’s annual independent director compensation program. Additionally, the Company has granted an aggregate total of 800,000 incentive stock options pursuant to the Company’s Stock Option Plan (the “Plan”) to officers of the Company. The incentive stock options are exercisable at a price of $0.90 per share, the last closing price per share on the Company’s common...

Continue reading

CohBar Announces Changes to its Board of Directors and R&D Leadership

Founding board members transition to reconstituted Scientific Advisory Board Kent Grindstaff, Ph.D. appointed as Senior Vice President of Research MENLO PARK, Calif., Dec. 17, 2021 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, today announced changes to its Board of Directors, Scientific Advisory Board (SAB), and R&D leadership. CohBar’s founders Drs. Nir Barzilai, Pinchas Cohen, and John Amatruda have transitioned from the company’s Board of Directors to a reconstituted SAB. The SAB will be comprised of experts in mitochondrial science and other disciplines, working with CohBar’s leadership to advance its pipeline and Mito+ platform. In addition, Ken Cundy, Ph.D. has resigned from his...

Continue reading

California Water Service Commits $200,000 to Advance Wildlife Preservation, Conservation Education Through Monterey Bay National Marine Sanctuary Foundation

SAN JOSE, Calif., Dec. 17, 2021 (GLOBE NEWSWIRE) — As part of its commitments to both furthering environmental stewardship and supporting education in socio-economically challenged areas it serves, California Water Service (Cal Water) has pledged $200,000 to the Monterey Bay National Marine Sanctuary Foundation (Foundation). The donation, announced at the Foundation’s holiday reception last night, will help the Foundation further its overall mission, including exploring future opportunities for youth education outreach programs across the region to deepen knowledge about conservation and how to protect marine wildlife and the ecosystem. The Foundation and Cal Water look forward to a long-term partnership dedicated to educating the next generation from areas such as Cal Water’s Salinas and King City districts at Monterey Bay, where...

Continue reading

Robotic Assistance Devices Receives Order for 10 ROSA Stationary Security Robots from Recently Signed Dealer Vista Security Group

Detroit, Michigan, Dec. 17, 2021 (GLOBE NEWSWIRE) — Artificial Intelligence Technology Solutions, Inc., (OTCPK:AITX), today announced that its wholly-owned subsidiary Robotic Assistance Devices Inc. (RAD) has received an order for 10 units of its popular ROSA (Responsive Observation Security Agent) security device from authorized dealer Vista Security Group, Inc. (VSG). “Vista Security Group came to us a few months back, signed as an authorized dealer just weeks ago, and today they place an order for 10 ROSAs,” said Mark Folmer, RAD President. “Things are certainly accelerating at RAD and having a solid dealer like VSG successfully promoting our solutions will further enhance this growth.” Although not identified due to existing non-disclosure agreements, RAD confirmed that the end user for these 10 ROSA deployments operates a...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.